CASE REPORT
Published on 10 Nov 2025
Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission
doi 10.3389/fimmu.2025.1684856
- 926 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Updates on the Management of Hematologic Malignancies from SOHO Italy: Educational Insights and Clinical Perspectives
Updates on the Management of Hematologic Malignancies from SOHO Italy: Educational Insights and Clinical Perspectives
8,761
Total downloads
34k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
BRIEF RESEARCH REPORT
Published on 06 Aug 2025
Current practices and challenges in the management of cancer-associated thrombosis: a survey of Italian oncologists
doi 10.3389/fonc.2025.1579464
- 1,223 views
- 1 citation
ORIGINAL RESEARCH
Published on 31 Oct 2024
The identification and correction of pseudohypercalcemia
doi 10.3389/fonc.2024.1441851
- 2,446 views
- 1 citation
MINI REVIEW
Published on 22 Oct 2024
The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma
doi 10.3389/fonc.2024.1392653
- 2,406 views
- 2 citations
REVIEW
Published on 29 Jul 2024
Novel insights and therapeutic approaches in secondary AML
doi 10.3389/fonc.2024.1400461
- 3,839 views
- 5 citations
REVIEW
Published on 16 May 2024
An overview of prognostic markers in patients with CLL
doi 10.3389/fonc.2024.1371057
- 8,455 views
- 19 citations
REVIEW
Published on 10 Apr 2024
Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
doi 10.3389/fonc.2024.1394048
- 8,137 views
- 11 citations
REVIEW
Published on 02 Apr 2024
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches
doi 10.3389/fonc.2024.1380358
- 6,705 views
- 22 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.